PH11041A - 3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof - Google Patents

3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof

Info

Publication number
PH11041A
PH11041A PH14508A PH14508A PH11041A PH 11041 A PH11041 A PH 11041A PH 14508 A PH14508 A PH 14508A PH 14508 A PH14508 A PH 14508A PH 11041 A PH11041 A PH 11041A
Authority
PH
Philippines
Prior art keywords
phenethylamine
dihydroxy
salts
alkyl
substituted phenyl
Prior art date
Application number
PH14508A
Inventor
J Mills
R Tuttle
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH11041(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH11041A publication Critical patent/PH11041A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH14508A 1972-04-12 1973-04-12 3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof PH11041A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
PH11041A true PH11041A (en) 1977-10-25

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
PH14508A PH11041A (en) 1972-04-12 1973-04-12 3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof

Country Status (31)

Country Link
JP (2) JPS5825656B2 (en)
KR (1) KR790000113B1 (en)
AR (1) AR203822A1 (en)
AT (1) AT323719B (en)
AU (1) AU472734B2 (en)
BE (1) BE798051A (en)
BG (1) BG23001A3 (en)
CA (1) CA1018188A (en)
CH (2) CH569691A5 (en)
CS (2) CS190448B2 (en)
CY (1) CY963A (en)
DD (1) DD107670B3 (en)
DE (1) DE2317710C2 (en)
DK (1) DK142750C (en)
ES (1) ES413639A1 (en)
FR (1) FR2182947B1 (en)
GB (1) GB1392674A (en)
HK (1) HK50178A (en)
HU (2) HU167597B (en)
IE (1) IE37511B1 (en)
IL (1) IL42016A (en)
KE (1) KE2870A (en)
MY (1) MY7800381A (en)
NL (1) NL174459C (en)
PH (1) PH11041A (en)
PL (2) PL90695B1 (en)
RO (2) RO65105A (en)
SE (1) SE399064B (en)
SU (1) SU496719A3 (en)
YU (2) YU36483B (en)
ZA (1) ZA732136B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (en) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (en) * 1983-09-16 1985-04-09 Shionogi & Co Ltd Oral dobutamine pharmaceutical
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (en) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (en) * 1993-04-13 1998-01-22 Duphar Int Res Manufacture of dobutamine compounds
PT1546088E (en) 2002-10-03 2015-03-16 Novaremed Ltd Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
JP2013501006A (en) 2009-07-31 2013-01-10 コグニション セラピューティクス インク． Cognitive decline inhibitors
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
BR112014004414A2 (en) * 2011-08-25 2017-03-28 Cognition Therapeutics Inc compositions and methods for treating neurodegenerative disease
BR112016017808B1 (en) 2014-01-31 2022-07-12 Cognition Therapeutics, Inc PHARMACEUTICALLY ACCEPTABLE COMPOUND OR SALT, USE OF A COMPOUND AND COMPOSITION FOR INHIBITING A BETAAMYLOID EFFECT IN A NEURONAL CELL
KR102614814B1 (en) 2017-05-15 2023-12-20 카그니션 테라퓨틱스, 인코퍼레이티드 Composition for treating neurodegenerative diseases
CN114524734B (en) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 Preparation method of dobutamine hydrochloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
YU36483B (en) 1984-02-29
AR203822A1 (en) 1975-10-31
CA1018188A (en) 1977-09-27
IL42016A (en) 1976-05-31
YU97673A (en) 1982-02-25
IE37511B1 (en) 1977-08-03
BG23001A3 (en) 1977-05-20
DE2317710C2 (en) 1983-08-04
PL94207B1 (en) 1977-07-30
ZA732136B (en) 1974-03-27
CH580563A5 (en) 1976-10-15
HU166213B (en) 1975-02-28
AU5438573A (en) 1974-10-17
DK142750C (en) 1981-08-17
DD107670B3 (en) 1988-04-06
YU37113B (en) 1984-08-31
NL7305097A (en) 1973-10-16
DD107670A5 (en) 1974-08-12
JPS5825656B2 (en) 1983-05-28
FR2182947A1 (en) 1973-12-14
RO65105A (en) 1980-01-15
CH569691A5 (en) 1975-11-28
KR790000113B1 (en) 1979-03-20
JPS58131945A (en) 1983-08-06
CY963A (en) 1978-12-22
SU496719A3 (en) 1975-12-25
BE798051A (en) 1973-10-11
AU472734B2 (en) 1976-06-03
SE399064B (en) 1978-01-30
DE2317710A1 (en) 1973-10-18
HU167597B (en) 1975-11-28
GB1392674A (en) 1975-04-30
HK50178A (en) 1978-09-15
DK142750B (en) 1981-01-12
IL42016A0 (en) 1973-06-29
JPS497237A (en) 1974-01-22
NL174459C (en) 1984-06-18
CS190406B2 (en) 1979-05-31
KE2870A (en) 1978-09-01
YU321279A (en) 1983-04-27
FR2182947B1 (en) 1976-07-02
AT323719B (en) 1975-07-25
NL174459B (en) 1984-01-16
PL90695B1 (en) 1977-01-31
JPS6221343B2 (en) 1987-05-12
RO70892A (en) 1982-02-26
CS190448B2 (en) 1979-05-31
MY7800381A (en) 1978-12-31
ES413639A1 (en) 1976-01-16

Similar Documents

Publication Publication Date Title
PH11041A (en) 3,4-dihydroxy-n((hydroxy substituted phenyl)-n-alkyl)-b-phenethylamine and salts thereof
KE2930A (en) Substituted 16,17,18,19,20-pentanorprostaglandins
CA1011741A (en) 5,6,7,8-tetrahydroquinoline-8-thiocarboxamides and related compounds
KE2670A (en) 1,2,3,-thiadiazole derivatives
PH12918A (en) 1,3-dioxo-2-aminoalkyl-4,4-dimethyl-isoquinolines and salts thereof
IL36949A0 (en) Substituted 2,2-diaryl-4-piperidino-butyramides and salts thereof,and their preparation
AU3031771A (en) New 2 amino-4-phenyl-thiazoles and their addition salts
GB1406961A (en) 2,4,7-trioxopteridine derivatives
ZA734996B (en) Oral composition
AU5852873A (en) Cardenolide-3-%2@-desoxy-glycosides<
GB1402046A (en) 11,12-epoxyerythromycins
JPS5745162A (en) Substituted 1,2,4,5-tetrahydro-3h,3-benzoazepines
JPS5119733A (en) Nn arukirudai 3 kyuamiruaminno seiho
HK15179A (en) 2,6-diaminoneburlarine derivatives
GB1373077A (en) Benzo-1,3,2-dioxapholphole derivatives
CA977758A (en) Exo-2-phenyl-bicyclo-(2,2,1)-heptane-2-(n-methyl-piperidol-4-)-carbonic-acid-ester and salts thereof
IL42431A0 (en) New substituted-quinolizinium salts and their preparation
AU6046473A (en) 1-aryl-2-arylalkyl-3-or-4%4@-%substituted-alkyl<-piperazino- 1@<-butanols- or-butenes-1
IL43436A0 (en) 11,12-secoprostaglandins and their manufacture
GB1404278A (en) 15,17a-unsubstituted-d-homosteroids
IL43666A0 (en) Substituted 9,10-dihydro-anthracenes
GB1400789A (en) 1,1-azobis-benzimidazolium salts
IL36977A0 (en) 2,6-methano-3-benzazocines and their preparation
PH10716A (en) O(-dl-4-acetoxy-1-methyl-3,3-diphenylhexylamine and salts
PH9640A (en) Tetraamino-substituted pyrimido-5,4-d-pyrimidines and salts thereof